Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 6.91M | 6.93M | 7.75M | 7.02M | 5.11M | 2.84M |
Gross Profit | 5.44M | 5.64M | 1.43M | 4.58M | 3.44M | 2.04M |
EBITDA | -3.37M | -3.55M | -7.85M | -11.37M | -4.53M | -4.90M |
Net Income | -4.21M | -4.30M | -8.52M | -11.91M | -5.07M | -9.67M |
Balance Sheet | ||||||
Total Assets | 10.52M | 8.62M | 4.52M | 11.91M | 17.77M | 22.52M |
Cash, Cash Equivalents and Short-Term Investments | 2.28M | 437.60K | 511.40K | 2.64M | 7.75M | 17.51M |
Total Debt | 61.62K | 1.78M | 365.35K | 3.24M | 264.16K | 730.47K |
Total Liabilities | 3.66M | 4.84M | 3.45M | 4.85M | 2.19M | 2.19M |
Stockholders Equity | 6.85M | 3.77M | 1.06M | 5.30M | 15.58M | 20.34M |
Cash Flow | ||||||
Free Cash Flow | -3.52M | -2.93M | -3.79M | -6.31M | -9.02M | -4.99M |
Operating Cash Flow | -3.51M | -2.91M | -3.79M | -6.23M | -8.98M | -4.95M |
Investing Cash Flow | -17.23K | -13.05K | -1.00K | -696.62K | -42.02K | -2.23M |
Financing Cash Flow | 4.41M | 2.83M | 1.43M | 1.90M | -218.60K | 24.09M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
64 Neutral | $10.95B | 16.37 | 8.81% | 1.96% | 2.68% | -15.33% | |
60 Neutral | $39.55M | 26.07 | 9.92% | ― | ― | ― | |
53 Neutral | $11.63M | ― | -28.37% | ― | -13.20% | -89.43% | |
47 Neutral | $5.15M | ― | -145.28% | ― | 13.96% | 85.22% | |
46 Neutral | $3.14M | ― | -191.47% | ― | -20.52% | 83.27% | |
― | $4.69M | ― | -126.65% | ― | ― | ― | |
43 Neutral | $59.67M | ― | -236.56% | ― | -6.61% | 40.20% |
On August 8, 2025, BIO-key International, Inc. held its Annual Meeting of Stockholders, where amendments to two stock plans were approved. The amendments increased the number of shares available for issuance under both the 2023 Stock Incentive Plan and the 2021 Employee Stock Purchase Plan by 700,000 shares each, potentially enhancing employee engagement and investment opportunities.
On August 8, 2025, BIO-key International, Inc. held its Annual Meeting of Stockholders, where several key proposals were approved. These included the election of board members, ratification of the company’s accounting firm, approval of executive compensation, and amendments to stock incentive and employee stock purchase plans. These decisions are expected to impact the company’s governance and operational strategies positively.